Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

